Boston Scientific Reports Q1 Sales Surge Amid Complex Guidance Revisions [TheStreet.com]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: TheStreet.com
by double-digit revenue growth across its core medical device portfolio . This strong start for the firm was driven primarily by high demand in its cardiovascular division. For the quarter ended March 31, 2026, the company reported total net sales of $5.203 billion. This figure represents an 11.6% increase on a reported basis compared to the prior year. Despite these top-line gains, the market reaction remained mixed as shareholders weighed the results against a revised annual forecast. Analyzing the Cardiovascular Sales Surge The Cardiovascular segment continues to be the primary engine of growth for the organization. In light of the latest filing, this division generated $3.50 billion in quarterly revenue. This reflects a significant 13.5% reported increase over the first quarter of 2025. The segment now accounts for approximately 67% of total company sales. Growth in this area is fueled by an aging global population and rapid physician adoption of new technologies. Specifically
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- Boston Scientific Just Slashed Guidance and Wall Street Followed. Is the Pullback a Buying Opportunity? [Yahoo! Finance]Yahoo! Finance
- Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX) was given a new $100.00 price target by Royal Bank Of Canada.MarketBeat
- Boston Scientific (BSX) was given a new $90.00 price target by Oppenheimer Holdings, Inc..MarketBeat
BSX
Earnings
- 4/22/26 - In-Line
BSX
Sec Filings
- 4/22/26 - Form 8-K
- 4/2/26 - Form EFFECT
- 4/1/26 - Form 424B3
- BSX's page on the SEC website